Jeremy Orr, MD, MPH: Disparities of AI Use During COVID-19


Some geographic areas are better equipped to deploy the technology.

Jeremy Orr, MD, MPH

Jeremy Orr, MD, MPH

Racial inequalities exist in healthcare, as they do in many other aspects of life. Geographic location plays a large in whether patients are able to access high quality care.

During the coronavirus disease 2019 (COVID-19) pandemic, these inequalities still exist. Only certain health systems have been able to leverage powerful technologies like artificial intelligence (AI) and machine learning to improve patient outcomes, Jeremy Orr, MD, MPH, chief executive officer of Medial EarlySign, said in a recent interview with HCPLive®.

The health systems benefitting from the technology are those who were early adopters and those that are culturally forward-thinking.

There is an ongoing trend that those that are high-performing and have their incentives aligned with a payer-provider set up and own the risk for a large population of patients are better off. That’s because they are incentivized to give their patients the best possible and most efficient care.

“We have to do more to have more organizations bear the long-term risks for their patients and move on from fee-for-service to fee-for-value and treat for health not profit from disease,” Orr said.

Health systems that are set up for that have better IT system, have better culture around them, and are doing the best, he added.

To hear more from Orr, watch the clip below.

Related Videos
Nanette B. Silverberg, MD: Uncovering Molluscum Epidemiology
Reviewing 2023 with FDA Commissioner Robert M. Califf, MD
A Year of RSV Highs and Lows, with Tina Tan, MD
Ryan A. Smith, MD: RSV Risk in Patients with IBD
Julia Moore Vogel, PhD, MBA: How Do We Define Long Covid Patients?
Julia Moore Vogel, PhD, MBA: Long Covid Care Lacks Urgency
Balancing COVID-19 Risk and Wellness in Patients with Rheumatic Diseases
Exploring Patient Experiences, Challenges of Rheumatic Disease Management During the Pandemic
Cedric Rutland, MD: Exploring Immunology's Role in Molecule Development
Cedric Rutland, MD: Mechanisms Behind Immunology, Cellular Communication
© 2024 MJH Life Sciences

All rights reserved.